Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
25.10
-0.18 (-0.71%)
Jul 4, 2025, 10:44 AM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Antihypertensive Active Pharmaceutical Ingredients and Intermediates | 1.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antihypertensive Active Pharmaceutical Ingredients and Intermediates Growth | -18.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anticoagulant Active Pharmaceutical Ingredients and Intermediates | 350.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anticoagulant Active Pharmaceutical Ingredients and Intermediates Growth | 71.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anti-asthma Active Pharmaceutical Ingredients and Intermediates | 169.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Anti-asthma Active Pharmaceutical Ingredients and Intermediates Growth | 22.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hypoglycemic Active Pharmaceutical Ingredients and Intermediates | 87.69M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hypoglycemic Active Pharmaceutical Ingredients and Intermediates Growth | -20.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Blood Lipid-lowering Active Pharmaceutical Ingredients and Intermediates | 58.75M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antiviral Active Pharmaceutical Ingredients and Intermediates | 45.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Antiviral Active Pharmaceutical Ingredients and Intermediates Growth | -37.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 188.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 26.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contract Manufacturing Organization | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Contract Manufacturing Organization Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 188.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 26.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 2.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -5.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|